Antisense inhibition of protein kinase Cα reverses the transformed phenotype in human lung carcinoma cells

Experimental Cell Research

Volumn 250, Issue 1, 1999, Pages 253-263

  Wang, Xiang Yang ^a,b   Repasky, Elizabeth ^b   Liu, Hui Tu ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

AP 1; Cell proliferation; Gene expression; Protein kinase C ; Signal transduction; Transformed phenotype

Indexed keywords

COMPLEMENTARY RNA; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; DNA BINDING; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CARCINOMA; MALIGNANT TRANSFORMATION; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033542806     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4529     Document Type: Article

References (72)

1. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature. 308:1984;693-698.
2. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and its activation of protein kinase C. Science. 258:1992;607-613.
3. Dekker L. V., Parker P. J. Protein kinase C - A question of specificity. Trends Biochem. Sci. 19:1994;73-77.
4. Mellor H., Parker P. J. The extended protein kinase C superfamily. Biochem. J. 332:1998;281-292.
5. Wang X-Y., Ostberg J. R., Repasky E. A. Effect of fever-like whole-body hyperthermia on lymphocyte spectrin distribution, protein kinase C activity, and uropod formation. J. Immunol. 162:1999;3378-3387.
6. Castagna M., Takai Y., Kaibuchi K., Sano K., Kikkiawa U., Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem. 257:1982;7847-7851.
7. Niedel J. E., Kuhn L. J., Vandenbark G. R. Phorbol diester receptor copurifies with protein kinase C. Proc. Natl. Acad. Sci. USA. 80:1983;36-40.
8. Housey G. M., Johnson M. D., Hsiao W. L. W., O'Brian C. A., Murphy J. P., Kirshmeier P., Weinstein I. B. Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell. 52:1988;343-354.
9. Cacace A. M., Guadagno S. N., Krauss R. S., Fabbro D., Weinstein I. B. The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene. 8:1993;2095-2104.
10. Persons D. A., Wilkison W. O., Bell R. M., Finn O. J. Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-I cDNA. Cell. 52:1988;447-458.
11. Mischak H., Goodnight J., Kolch W., Martiny-Baron G., Schaechtle C., Kazanietz M. G., Blumberg P. M., Pierce J. H., Mushinski J. F. Overexpression of protein kinase C-δ and -ε in NIH3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J. Biol. Chem. 268:1993;6090-6096.
12. Borner C., Ueffing M., Jaken S., Parker P. J., Weinstein I. B. Two closely related isoforms of protein kinase C produce reciprocal effects on the growth of rat fibroblasts. J. Biol. Chem. 270:1995;78-86.
13. Ways D. K., Kukoly C. A., deVente J., Hooker J. L., Bryant W. O., Posekany K. J., Fletcher D. J., Cook P. P., Parker P. J. MCF-7 breast cancer cells transfected with PKC-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J. Clin. Invest. 95:1995;1906-1915.
14. Choi P. L., Tchou-Wong K-M., Weinstein I. B. Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression. Mol. Cell Biol. 10:1990;4650-4657.
15. Watanable T., Ono Y., Taniyama Y., Hazama K., Igarashi K., Ogita K., Kikkawa U., Nishizuka Y. Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-δ subspecies. Proc. Natl. Acad. Sci. USA. 89:1992;10159-10163.
16. Takenaga K., Takahashi K. Effects of 12-O-tetradecanoylphorbol-13-acetate on adhesiveness and lung-colonizing ability of Lewis lung carcinoma cells. Cancer Res. 46:1986;375-380.
17. Gopalakrishna R., Barsky S. H. Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis. Proc. Natl. Acad. Sci. USA. 85:1988;612-616.
18. 2+ mobilization and protein kinase C activation in the induction of spontaneous metastasis by mouse mammary adenocarcinoma cells. Cancer Res. 49:1989;2597-2602.
19. Schwartz G. K., Jiang K., Kelsen D., Albino A. P. Protein kinase C: a novel target for inhibiting gastric cancer cell invasion. J. Natl. Cancer Inst. 85:1993;402-407.
20. Herbert J. M. Protein kinase C: A key factor in the regulation of tumor cell adhesion to the endothelium. Biochem. Pharmacol. 45:1993;527-537.
21. Lane T. A., Lamkin G. E., Wancewicz E. Modulation of endothelial cell expression of intracellular adhesion molecule 1 by protein kinase C activation. Biochem. Biophys. Res. Commun. 161:1989;945-952.
22. Parker P. J., Coussens L., Totty N., Rhee L., Young S., Chen E., Stabel S., Waterfield M. D., Ullrich A. The complete primary structure of protein kinase C-the major phorbol ester receptor. Science. 233:1986;853-859.
23. c-src by overexpression of a protein tyrosine phosphatase. Nature. 359:1992;336-339.
24. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
25. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
26. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:1976;248-254.
27. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
28. Bohmann D., Bos T. J., Admon A., Nishimura T., Vogt P. K., Tijian R. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science. 238:1987;1386-1392.
29. Chiu R., Boyle W. J., Meek J., Smeal T., Hunter T., Karin M. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell. 54:1998;541-552.
30. Halazonetis T. D., Georgopoulos K., Greenberg M. E., Leder P. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell. 55:1988;917-924.
31. Yamaguchi K., Ogita K., Nakamura S., Nishizuka Y. The protein kinase C isoforms leading to MAP-kinase activation in CHO cells. Biochem. Biophys. Res. Commun. 210:1995;251-255.
32. Dunn J. A., Faletto M. B., Kasper S. J., Gurtoo H. L. Aflatoxin-transformed C3H10T1/2 cells overexpress protein kinase C and have an altered response to phorbol ester treatments. Cancer Res. 52:1992;990-996.
33. Eldar H., Zisman Y., Ullrich A., Liveneh E. Overexpression of protein kinase Cα-subtype in Swiss/3T3 fibroblasts causes loss of both high and low affinity receptor numbers for epidermal growth factor. J. Biol. Chem. 265:1990;13290-13296.
34. Baltuch G. H., Dooley N. P. D., Rostworowski M., Villemure J-G., Yong V. W. Protein kinase C isoform α overexpression in C6 glioma cells and its role in cell proliferation. J. Neuro-oncology. 24:1995;241-250.
35. Chakrabarty S., Huang S. Role of protein kinase Cα in the induction of carcinoembryonic antigen by transforming growth factor βI. J. Cell Physiol. 164:1995;148-153.
36. Wang S., Desai D., Wright G., Niles R. M., Wright G. L. Effects of protein kinase Cα overexpression on A7r5 smooth muscle cell proliferation and differentiation. Exp. Cell Res. 236:1997;117-126.
37. Gruber J. R., Ohno S., Niles R. M. Increased expression of protein kinase Cα plays a key role in retinoic acid-induced melanoma differentiation. J. Biol. Chem. 267:1992;13356-13360.
38. Scaglione-Sewell B., Abraham C., Bissonnette M., Skarosi S. F., Hart J., Davidson N. O., Wali R. K., Davis B. H., Sitrin M., Brasitus T. A. Decreased PKC-α expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells. Cancer Res. 58:1998;1074-1081.
39. Biswas P., Abboud H. E., Kiyomoto H., Wenzel U. O., Grandaliano G., Choudhury G. G. PKC alpha regulates thrombin-induced PDGF-B chain gene expression in mesangial cells. FEBS Lett. 373:1995;146-150.
40. Caponigro F., French R. C., Kaye S. B. Protein kinase C: A worthwhile target for anticancer drugs. Anticancer Drugs. 8:1997;26-33.
41. Geiger T., Muller M., Dean N. M., Fabbro D. Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice. Anti-cancer Drug Design. 13:1998;35-45.
42. Sioud M., Sørensen D. R. A nuclease-resistant protein kinase Cα ribozyme blocks glioma cell growth. Nature Biotechnology. 16:1998;556-561.
43. Baranes D., Razin E. Protein kinase C regulates proliferation of mast cells and the expression of the mRNAs of fos and jun protooncogenes during activation by IgE-Ag or calcium ionophore A23187. Blood. 78:1991;2354-2359.
44. Downward J., Graves J., Cantrell D. The regulation and function of p21 ras in T cells. Immunol. Today. 13:1992;89-92.
45. Szamel M., Resch K. T-cell antigen receptor-induced signal-transduction pathways activation and function of protein kinase C in T lymphocytes. Eur. J. Biochem. 228:1995;1-15.
46. Krook A., Rapoport M. J., Anderson S., Pross H., Zhou Y. C., Denhardt D. T., Delovitch T. L., Haliotis T. p21 and protein kinase C function in distinct and interdependent signaling pathways in C3H10T1/2 fibroblasts. Mol. Cell Biol. 13:1993;1471-1479.
47. Dlugosz A. A., Cheng C., Williams E. K., Dharia A. G., Denning M. F., Yuspa S. H. Alterations in murine keratinocyte differentiation induced by activated Ha-ras genes are mediated by protein kinase C-α Cancer Res. 54:1994;6413-6420.
48. Delage S., Chastre E., Empereur S., Wicek D., Veissiére D., Capeau J., Gespach C., Cherqui G. Increased protein kinase Cα expression in human colonic Caco-2 cells after insertion of human Ha-ras or polyoma virus middle T oncogenes. Cancer Res. 53:1993;2762-2770.
49. Borner C., Guadagno S. N., Hsieh L-L., Hsiao W-L. W., Weinstein I. B. Transformation by a ras oncogene causes increased expression of protein kinase C-α and a decreased expression of protein kinase C-ε Cell Growth Differ. 1:1990;653-660.
50. Hsiao W-L. W., Housey G. M., Johnson M. D., Weinstein I. B. Cells that overproduce protein kinase C are more susceptible to transformation by an activated H-ras oncogene. Mol. Cell Biol. 9:1989;2641-2647.
51. Kampfer S., Hellbert K., Villunger A., Doppler W., Baier G., Grunicke H. H., Uberall F. Transcriptional activation of c-fos by oncogenic Ha-ras in mouse mammary epithelial cells requires the combined activities of PKC-lambda, epsilon and zeta. EMBO J. 17:1998;4046-4055.
52. Woodgett J. R., Pulverer B. J., Nikolakaki E., Plyte S., Hughes K., Franklin C. C., Kraft A. S. Regulation of Jun/AP-1 oncoproteins by protein phosphorylation. Adv. Second Messenger Phosphoprotein Res. 28:1993;261-269.
53. Fung H., Quinlan T. R., Janssen Y. M. W., Timblin C. R., Marsh J. P., Heintz N. H., Taatjes D. J., Vacek P., Jaken S., Mossman B. T. Inhibition of protein kinase C prevents asbestos-induced c-fos and c-jun proto-oncogene expression in mesothelial cells. Cancer Res. 57:1997;3101-3105.
54. Uberall F., Kampfer S., Doppler W., Grunicke H. H. Activation of c-fos expression by transforming Ha-ras in HC11 mouse mammary epithelial cells is PKC-dependent and mediated by serum responsive element. Cell Signaling. 6:1994;285-297.
55. Lewin B. I., Nechushtan H., Ke Q., Razin E. Regulation of AP-1 expression and activity in antigen-stimulated mast cells: The role played by protein kinase C and the possible involvement of Fos interacting protein. Blood. 82:1993;3745-3751.
56. Angel P., Karin M. The role of Jun, Fos and the Ap-1 complex in cell proliferation and transformation. Biochem. Biophys. Acta. 1072:1991;129-157.
57. Boyle W. J., Smeal T., Defize L. H. K., Angel P., Woodgett J. R., Karin M., Hunter T. Activation of protein kinase C decreases phosphorylation of c-jun at sites that negatively regulate its DNA-binding activity. Cell. 64:1991;573-584.
58. Smeal T., Binétruy B., Mercola D. A., Birrer M., Karin M. Phosphorylation of c-Jun on serines 63 and 73 is required for oncogenic and transcriptional cooperation with Ha-Ras. Nature (London). 354:1991;494-496.
59. Morrison P., Saltiel A. R., Rosner M. R. Role of mitogen-activated protein kinase kinase in regulation of the epidermal growth factor receptor by protein kinase C. J. Biol. Chem. 271:1996;12891-12896.
60. Marquardt B., Frith D., Stabel S. Signaling from TPA to MAP kinase requires protein kinase C, raf and MEK: Reconstitution of the signaling pathway in vitro. Oncogene. 9:1994;3213-3218.
61. Zou Y., Komuro I., Yamazaki T., Aikawa R., Kudoh S., Shiojima I., Hiroi Y., Mizuno T., Yazaki Y. Protein kinase C, but not tyrosine kinase or Ras, plays a critical role in angiotensin II-induced activation of Raf-1 kinase and extracellular signal-regulated protein kinases in cardiac myocytes. J. Biol. Chem. 271:1996;33592-33597.
62. Schönwasser D. C., Marais R. M., Marshall C. J., Parker P. J. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol. Cell. Biol. 18:1998;790-798.
63. Cai H., Smola U., Wixler V., Eisenmann-Tappe I., Diaz-Meco M. T., Moscat J., Rapp U., Cooper G. M. Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Mol. Cell Biol. 17:1997;732-741.
64. Kolch W., Heidecker G., Kochs G., Hummel R., Vahidi H., Mischak H., Finkenzeller G., Marme D., Rapp U. R. Protein kinase C α activates RAF-1 by direct phosphorylation. Nature. 364:1993;249-252.
65. Sözeri O., Vollmer K., Liyanage M., Frith D., Kour G., Mark G. E. III, Stabel S. Activation of the c-Raf protein kinase by protein kinase C phosphorylation. Oncogene. 7:1992;2259-2262.
66. Pulverer B. J., Kyriakis J. M., Avruch J., Nikolakaki E., Woodgett J. R. Phosphorylation of c-Jun mediated by MAP-kinase. Nature (London). 353:1991;670-674.
67. Olson E. N., Burgess R., Staudinger J. Protein kinase C as a transducer of nuclear signal. Cell Growth Differ. 4:1993;699-705.
68. Bsckmann R., Buchner K., Jungblut P. R., Eckerskorn C., Weise C., Hilbert R., Hucho F. Nuclear substrates of protein kinase C. Eur. J. Biochem. 210:1992;45-51.
69. Yu G., Ahmad S., Aquino A., Fairchild C. R., Trepel J. B., Ohno S. Transfection with protein kinase Cα confers increased multidrug resistance to MCF-7 cells overexpressing P-glycoprotein. Cancer Commun. 3:1991;181-189.
70. Ahmad S., Glazer R. I. Expression of the antisense cDNA for protein kinase Cα attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells. Mol. Pharmacol. 43:1993;858-862.
71. Wang X-Y., Liu H. T. Antisense expression of protein kinase Cα improved sensitivity to anticancer drugs in human lung cancer LTEPa-2 cells. Acta Pharmacol. Sinica. 19:1998;265-268.
72. Basu A. The potential of protein kinase C as a target for anticancer treatment. Pharmacol. Ther. 59:1993;257-280.